Cote d'Ivoire vs India: Cause of death, by non-communicable diseases, ages 15-59, male
Cote d'Ivoire
41.5%
in 2021
India
42.1%
in 2021
Cote d'Ivoire rank
127th
India rank
124th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Cote d'Ivoire
- India
How they compare
India currently reports 42.1% against 41.5% in Cote d'Ivoire, a difference of 0.6%.
Across all 6 years both countries report, India has been ahead every year.
Cote d'Ivoire ranks 127th and India ranks 124th of 185 countries.
India has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | India | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.0% | 42.2% | 22.2% | India |
| 2010s | 37.5% | 57.7% | 20.2% | India |
| 2020s | 41.7% | 49.8% | 8.0% | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Cote d'Ivoire or India?
- India, at 42.1% against 41.5% in Cote d'Ivoire as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Cote d'Ivoire and India?
- 0.6%, with India ahead.
- How many years of comparable data are there for Cote d'Ivoire and India?
- 6 years are reported by both, from 2000 to 2021.
- How do Cote d'Ivoire and India rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Cote d'Ivoire ranks 127th and India ranks 124th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.